Survivin inhibition with YM155 ameliorates experimental pulmonary arterial hypertension

  1. Blanco, I.
  2. Marquina, M.
  3. Tura-Ceide, O.
  4. Ferrer, E.
  5. Ramírez, A.M.
  6. Lopez-Meseguer, M.
  7. Callejo, M.
  8. Perez-Vizcaino, F.
  9. Peinado, V.I.
  10. Barberà, J.A.
Aldizkaria:
Frontiers in Pharmacology

ISSN: 1663-9812

Argitalpen urtea: 2023

Alea: 14

Mota: Artikulua

DOI: 10.3389/FPHAR.2023.1145994 GOOGLE SCHOLAR lock_openSarbide irekia editor
Datuen iturria: Scopus